NCT02845401View on ClinicalTrials.gov

The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).

NAActive, not recruitingINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

November 17, 2016

Primary Completion Date

May 25, 2026

Study Completion Date

May 31, 2026

Conditions
Chronic Hepatitis B Virus
Interventions
OTHER

Stop NA therapy

Cases will stop antiviral therapy

Trial Locations (2)

94115

California Pacific Medical Center, San Francisco

94122

University of California, San Francisco, San Francisco

Sponsors
All Listed Sponsors
collaborator

University of California, San Francisco

OTHER

lead

California Pacific Medical Center Research Institute

OTHER